© 2022 MJH Life Sciences and Pharmacy Times. All rights reserved.
© 2022 MJH Life Sciences™ and Pharmacy Times. All rights reserved.
September 03, 2015
The first biosimilar to receive FDA approval is now available the United States.
August 27, 2015
The FDA today approved evolocumab (Repatha) injection, a new treatment for patients unable to get their low-density lipoprotein (LDL) cholesterol under control with current treatment options.